Zai Lab(ZLAB)
CA - South SFBiotechnology
Focus: Zai Lab is a public biotech company developing small-molecule and biologic therapies across oncology, immunology, and rare disease indications. The company operates at commercial scale with $267M in FY2025 revenue and a diversified pipeline of 30 active programs.
Profile data last refreshed 18h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Total Funding
$858M
Open Jobs
0
About Zai Lab
AI assessmentNot HiringNo open roles listed right now. Follow Zai Lab to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Zai Lab's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
9 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$267M
Key Products
Peak9.7yr
Lead marketed product with 11-year exclusivity runway; key revenue driver for company profitability trajectory.
Help build intelligence for Zai Lab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.